RSS   Newsletter   Contact   Advertise with us
Post Online Media

Takeda gets clearance for Shire deal from U.S. FTC

Share on Twitter Share on LinkedIn
Staff Writer | Tuesday July 10, 2018 8:33AM ET
Acquisition   The deal remains subject to a number of conditions

Takeda Pharmaceutical has been given permission by the U.S. consumer protection agency for its takeover of UK drug-maker Shire.

Takeda said on Tuesday morning that its has received unconditional clearance from the Federal Trade Commission for the proposed acquisition.

The deal remains subject to a number of conditions, including receipt of other regulatory clearances and approval by the shareholders of both companies.

"The FTC's unconditional clearance of the acquisition is another significant milestone in the transaction process," Takeda said.


What to read next
POST Online Media Contact

 More inside POST